Profile
Dr. Greengard is among the leading scientists studying nerve cell communication.
He was the Vincent Astor Professor of Molecular & Cellular Neuroscience at Rockefeller University, and winner of the Nobel Prize in Medicine in 2000.
Dr. Greengard received his PhD from Johns Hopkins University.
Former positions of Paul Greengard
| Companies | Position | End |
|---|---|---|
Intra-Cellular Therapies, Inc. /Old/
 Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY. | Founder | - |
| INTRA-CELLULAR THERAPIES, INC. | Founder | - |
Pulsar Ventures LLC
 Pulsar Ventures LLC Investment ManagersFinance Pulsar Ventures LLC is a venture capital firm founded in 2002. The firm is headquartered in Half Moon Bay, California. | Corporate Officer/Principal | - |
Training of Paul Greengard
| The Johns Hopkins University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| INTRA-CELLULAR THERAPIES, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Pulsar Ventures LLC
Pulsar Ventures LLC Investment ManagersFinance Pulsar Ventures LLC is a venture capital firm founded in 2002. The firm is headquartered in Half Moon Bay, California. | Finance |
Intra-Cellular Therapies, Inc. /Old/
Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Paul Greengard
